Suchergebnisse - "Zhao, Qian"

PubPharm (55)

1

Platinum Resistance After PARPi Resistance in a gBRCAmt Recurrent Ovarian Cancer Patient : a Case Report

enthalten in: Reproductive sciences (Thousand Oaks, Calif.) | 2023

von Zhao, Q. | Ni, J. | Dong, J. | +6

2

First-in-human phase I dose-escalation and dose-expansion trial of the selective MEK inhibitor HL-085 in patients with advanced melanoma harboring NRAS mutations

enthalten in: BMC medicine | 2023

von Wang, X. | Luo, Z. | Chen, J. | +10

3

Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy : from molecular mechanisms to potential therapeutic targets

enthalten in: Journal of hematology & oncology | 2022

von Qin, R. | You, F. | Zhao, Q. | +4

ErratumIn: J Hematol Oncol. 2022 Oct 24;15(1):151. - PMID 36280887

4

Design, Synthesis, and Biological Evaluation of Tetrahydro-α-carbolines as Akt1 Inhibitors That Inhibit Colorectal Cancer Cell Proliferation

enthalten in: ChemMedChem | 2022

von Li, G. | He, X. | Li, H. | +6

5

Advances in indole-containing alkaloids as potential anticancer agents by regulating autophagy

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2022

von Luo, M. | Huang, W. | Zhu, H. | +3

6

CHMFL-BMX-078, a BMX inhibitor, overcomes the resistance of melanoma to vemurafenib via inhibiting AKT pathway

enthalten in: Chemico-biological interactions | 2022

von Jiang, S. | Jiang, T. | Huang, H. | +7

7

Response prediction biomarkers and drug combinations of PARP inhibitors in prostate cancer

enthalten in: Acta pharmacologica Sinica | 2021

von Chen, Y. | Tan, L. | Gong, J. | +5

8

eIF3a R803K mutation mediates chemotherapy resistance by inducing cellular senescence in small cell lung cancer

enthalten in: Pharmacological research | 2021

von Chen, Y. | Wang, C. | Xiao, D. | +6

9

EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma

enthalten in: Cancer research | 2021

von Leung, H. | Leung, C. | Lau, E. | +11

CommentIn: Stem Cell Investig. 2022 Oct 19;9:5. - PMID 36320882

10

Design, synthesis, and biological evaluation of nitroisoxazole-containing spiro[pyrrolidin-oxindole] derivatives as novel glutathione peroxidase 4/mouse double minute 2 dual inhibitors that inhibit breast adenocarcinoma cell proliferation

enthalten in: European journal of medicinal chemistry | 2021

von Liu, S. | Zhao, Q. | Peng, C. | +6

1
2
3
4
5
6
Nächster »
[6]